Risk factors for methicillin-resistant staphylococcal vascular graft infection in an 11-year cohort study

Journal of Infection

Volumn 64, Issue 4, 2012, Pages 441-444

  Legout, Laurence ^a   D'Elia, Piervito ^b   Devos, Patrick ^c   Ettahar, Nicolas ^c   Sarraz Bournet, Beatrice ^c   Haulon, Stephan ^a   Senneville, Eric ^c   Leroy, Olivier ^b  

^a Dron Hospital   (France)

^b Dron Hospital of Tourcoing   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DAPTOMYCIN; VANCOMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD CULTURE; BLOOD SAMPLING; CAUSAL ATTRIBUTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; FEMALE; GRAFT INFECTION; HUMAN; HYPERTENSION; INTRAOPERATIVE PERIOD; LETTER; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS VASCULAR GRAFT INFECTION; MINIMUM INHIBITORY CONCENTRATION; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BLOOD VESSEL PROSTHESIS; COHORT STUDIES; FEMALE; FRANCE; HUMANS; LOGISTIC MODELS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VASCULAR SURGICAL PROCEDURES; YOUNG ADULT;

EID: 84858444963     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.12.021     Document Type: Letter

References (16)

1. Szczot M., Meybeck A., Legout L., Pasquet A., Van Grunderbeeck N., Langlois J., et al. Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. J Infect 2011 Mar, 62(3):204-211.
2. FitzGerald S.F., Kelly C., Humphreys H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother 2005 Dec, 56(6):996-999.
3. Bandyk D.F., Esses G.E. Prosthetic graft infection. Surg Clin North Am 1994 Jun, 74(3):571-590.
4. Bandyk D.F. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg 2008 Sep, 21(3):119-123.
5. Nasim A., Thompson M.M., Naylor A.R., Bell P.R., London N.J. The impact of MRSA on vascular surgery. Eur J Vasc Endovasc Surg 2001 Sep, 22(3):211-214.
6. Leseche G., Castier Y., Petit M.D., Bertrand P., Kitzis M., Mussot S., et al. Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg 2001 Oct, 34(4):616-622.
7. Noel A.A., Gloviczki P., Cherry K.J., Safi H., Goldstone J., Morasch M.D., et al. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg 2002 May, 35(5):847-852.
8. Antonios V.S., Noel A.A., Steckelberg J.M., Wilson W.R., Mandrekar J.N., Harmsen W.S., et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect 2006 Jul, 53(1):49-55.
9. Batt M., Jean-Baptiste E., O'Connor S., Bouillanne P.J., Haudebourg P., Hassen-Khodja R., et al. In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. Eur J Vasc Endovasc Surg 2008 Aug, 36(2):182-188.
10. Ali A.T., Modrall J.G., Hocking J., Valentine R.J., Spencer H., Eidt J.F., et al. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts. J Vasc Surg 2009 Jul, 50(1):30-39.
11. LaPlante K.L., Rybak M.J. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2004 Dec, 48(12):4665-4672.
12. Edmiston C.E., Goheen M.P., Seabrook G.R., Johnson C.P., Lewis B.D., Brown K.R., et al. Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am J Surg 2006 Sep, 192(3):344-354.
13. Smith K., Perez A., Ramage G., Gemmell C.G., Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of methicillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents 2009 Apr, 33(4):374-378.
14. Cirioni O., Mocchegiani F., Ghiselli R., Silvestri C., Gabrielli E., Marchionni E., et al. Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection. Eur J Vasc Endovasc Surg 2010 Dec, 40(6):817-822.
15. Bisdas T., Wilhelmi M., Haverich A., Teebken O.E. Cryopreserved arterial homografts vs silver-coated Dacron grafts for abdominal aortic infections with intraoperative evidence of microorganisms. J Vasc Surg 2011 May, 53(5). 1274-1281 e4.
16. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 Mar 16, 130(6):461-470.